img

Global and United States Peptide CDMO Services Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States Peptide CDMO Services Market Report & Forecast 2024-2034

Peptide CDMO services refer to peptide drug development and manufacturing outsourcing services. Polypeptides are short-chain proteins composed of amino acids and have a wide range of biological activities and pharmacological applications.
Market Analysis and InsightsGlobal and United States Peptide CDMO Services Market
This report focuses on global and United States Peptide CDMO Services market, also covers the segmentation data of other regions in regional level and county level.
The global Peptide CDMO Services revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
Peptide CDMO services usually cover the following aspectspeptide synthesis, process development, quality control, scale production, injection preparation. By choosing peptide CDMO services, the development and manufacture of peptide drugs can be handed over to professional institutions, thereby saving time, reducing costs, and ensuring product quality and compliance.
Global Peptide CDMO Services Scope and Market Size
Peptide CDMO Services market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Peptide CDMO Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Peptide CDMO Services market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Incyte
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Sinopep
Frontier Biotechnologies
JYMed
Chengdu Shengnuo Biotechnology
Shanghai Soho-Yiming Pharmaceuticals
Chinese Peptide Company
Ambio Pharmaceuticals
Zhejiang Peptites Biotech
STA Pharmaceutical
Segment by Type
Small Molecule CDMO
Macro-molecular CDMO

Segment by Application


Clinical Treatment
Medical Research
Commercial Production
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Peptide CDMO Services definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Peptide CDMO Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Peptide CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide CDMO Services revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Peptide CDMO Services Product Introduction
1.2 Global Peptide CDMO Services Outlook 2018 VS 2022 VS 2033
1.2.1 Global Peptide CDMO Services Market Size for the Year 2018-2033
1.2.2 United States Peptide CDMO Services Market Size for the Year 2018-2033
1.3 Peptide CDMO Services Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Peptide CDMO Services in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Peptide CDMO Services Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Peptide CDMO Services Market Dynamics
1.4.1 Peptide CDMO Services Industry Trends
1.4.2 Peptide CDMO Services Market Drivers
1.4.3 Peptide CDMO Services Market Challenges
1.4.4 Peptide CDMO Services Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Peptide CDMO Services by Type
2.1 Peptide CDMO Services Market Segment by Type
2.1.1 Small Molecule CDMO
2.1.2 Macro-molecular CDMO
2.2 Global Peptide CDMO Services Market Size by Type (2018, 2022 & 2033)
2.3 Global Peptide CDMO Services Market Size by Type (2018-2033)
2.4 United States Peptide CDMO Services Market Size by Type (2018, 2022 & 2033)
2.5 United States Peptide CDMO Services Market Size by Type (2018-2033)
3 Peptide CDMO Services by Application
3.1 Peptide CDMO Services Market Segment by Application
3.1.1 Clinical Treatment
3.1.2 Medical Research
3.1.3 Commercial Production
3.2 Global Peptide CDMO Services Market Size by Application (2018, 2022 & 2033)
3.3 Global Peptide CDMO Services Market Size by Application (2018-2033)
3.4 United States Peptide CDMO Services Market Size by Application (2018, 2022 & 2033)
3.5 United States Peptide CDMO Services Market Size by Application (2018-2033)
4 Global Peptide CDMO Services Competitor Landscape by Company
4.1 Global Peptide CDMO Services Market Size by Company
4.1.1 Global Key Companies of Peptide CDMO Services, Ranked by Revenue (2022)
4.1.2 Global Peptide CDMO Services Revenue by Player (2018-2023)
4.2 Global Peptide CDMO Services Concentration Ratio (CR)
4.2.1 Peptide CDMO Services Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Peptide CDMO Services in 2022
4.2.3 Global Peptide CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Peptide CDMO Services Head office and Area Served
4.4 Global Key Players of Peptide CDMO Services, Product and Application
4.5 Global Key Players of Peptide CDMO Services, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Peptide CDMO Services Market Size by Company
4.7.1 Key Players of Peptide CDMO Services in United States, Ranked by Revenue (2022)
4.7.2 United States Peptide CDMO Services Revenue by Players (2021, 2022 & 2023)
5 Global Peptide CDMO Services Market Size by Region
5.1 Global Peptide CDMO Services Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Peptide CDMO Services Market Size by Region (2018-2033)
5.2.1 Global Peptide CDMO Services Market Size by Region: 2018-2023
5.2.2 Global Peptide CDMO Services Market Size by Region (2024-2033)
6 Americas
6.1 Americas Peptide CDMO Services Market Size YoY Growth 2018-2033
6.2 Americas Peptide CDMO Services Market Size by Type
6.2.1 Americas Peptide CDMO Services Market Size by Type (2018-2023)
6.2.2 Americas Peptide CDMO Services Market Size by Type (2024-2033)
6.2.3 Americas Peptide CDMO Services Market Share by Type (2018-2033)
6.3 Americas Peptide CDMO Services Market Size by Application
6.3.1 Americas Peptide CDMO Services Market Size by Application (2018-2023)
6.3.2 Americas Peptide CDMO Services Market Size by Application (2024-2033)
6.3.3 Americas Peptide CDMO Services Market Share by Application (2018-2033)
6.4 Americas Peptide CDMO Services Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Peptide CDMO Services Market Size YoY Growth 2018-2033
7.2 EMEA Peptide CDMO Services Market Size by Type
7.2.1 EMEA Peptide CDMO Services Market Size by Type (2018-2023)
7.2.2 EMEA Peptide CDMO Services Market Size by Type (2024-2033)
7.2.3 EMEA Peptide CDMO Services Market Share by Type (2018-2033)
7.3 EMEA Peptide CDMO Services Market Size by Application
7.3.1 EMEA Peptide CDMO Services Market Size by Application (2018-2023)
7.3.2 EMEA Peptide CDMO Services Market Size by Application (2024-2033)
7.3.3 EMEA Peptide CDMO Services Market Share by Application (2018-2033)
7.4 EMEA Peptide CDMO Services Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Peptide CDMO Services Market Size YoY Growth 2018-2033
8.2 China Peptide CDMO Services Market Size by Type
8.2.1 China Peptide CDMO Services Market Size by Type (2018-2023)
8.2.2 China Peptide CDMO Services Market Size by Type (2024-2033)
8.2.3 China Peptide CDMO Services Market Share by Type (2018-2033)
8.3 China Peptide CDMO Services Market Size by Application
8.3.1 China Peptide CDMO Services Market Size by Application (2018-2023)
8.3.2 China Peptide CDMO Services Market Size by Application (2024-2033)
8.3.3 China Peptide CDMO Services Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Peptide CDMO Services Market Size YoY Growth 2018-2033
9.2 APAC Peptide CDMO Services Market Size by Type
9.2.1 APAC Peptide CDMO Services Market Size by Type (2018-2023)
9.2.2 APAC Peptide CDMO Services Market Size by Type (2024-2033)
9.2.3 APAC Peptide CDMO Services Market Share by Type (2018-2033)
9.3 APAC Peptide CDMO Services Market Size by Application
9.3.1 APAC Peptide CDMO Services Market Size by Application (2018-2023)
9.3.2 APAC Peptide CDMO Services Market Size by Application (2024-2033)
9.3.3 APAC Peptide CDMO Services Market Share by Application (2018-2033)
9.4 APAC Peptide CDMO Services Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Incyte
10.1.1 Incyte Company Details
10.1.2 Incyte Business Overview
10.1.3 Incyte Peptide CDMO Services Introduction
10.1.4 Incyte Revenue in Peptide CDMO Services Business (2018-2023)
10.1.5 Incyte Recent Development
10.2 Gliead
10.2.1 Gliead Company Details
10.2.2 Gliead Business Overview
10.2.3 Gliead Peptide CDMO Services Introduction
10.2.4 Gliead Revenue in Peptide CDMO Services Business (2018-2023)
10.2.5 Gliead Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Details
10.3.2 Boehringer Ingelheim Business Overview
10.3.3 Boehringer Ingelheim Peptide CDMO Services Introduction
10.3.4 Boehringer Ingelheim Revenue in Peptide CDMO Services Business (2018-2023)
10.3.5 Boehringer Ingelheim Recent Development
10.4 Vertex
10.4.1 Vertex Company Details
10.4.2 Vertex Business Overview
10.4.3 Vertex Peptide CDMO Services Introduction
10.4.4 Vertex Revenue in Peptide CDMO Services Business (2018-2023)
10.4.5 Vertex Recent Development
10.5 Mirati Therapeutics
10.5.1 Mirati Therapeutics Company Details
10.5.2 Mirati Therapeutics Business Overview
10.5.3 Mirati Therapeutics Peptide CDMO Services Introduction
10.5.4 Mirati Therapeutics Revenue in Peptide CDMO Services Business (2018-2023)
10.5.5 Mirati Therapeutics Recent Development
10.6 AMPAC
10.6.1 AMPAC Company Details
10.6.2 AMPAC Business Overview
10.6.3 AMPAC Peptide CDMO Services Introduction
10.6.4 AMPAC Revenue in Peptide CDMO Services Business (2018-2023)
10.6.5 AMPAC Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Details
10.7.2 Pfizer Business Overview
10.7.3 Pfizer Peptide CDMO Services Introduction
10.7.4 Pfizer Revenue in Peptide CDMO Services Business (2018-2023)
10.7.5 Pfizer Recent Development
10.8 Polypeptide
10.8.1 Polypeptide Company Details
10.8.2 Polypeptide Business Overview
10.8.3 Polypeptide Peptide CDMO Services Introduction
10.8.4 Polypeptide Revenue in Peptide CDMO Services Business (2018-2023)
10.8.5 Polypeptide Recent Development
10.9 Bachem
10.9.1 Bachem Company Details
10.9.2 Bachem Business Overview
10.9.3 Bachem Peptide CDMO Services Introduction
10.9.4 Bachem Revenue in Peptide CDMO Services Business (2018-2023)
10.9.5 Bachem Recent Development
10.10 Merck
10.10.1 Merck Company Details
10.10.2 Merck Business Overview
10.10.3 Merck Peptide CDMO Services Introduction
10.10.4 Merck Revenue in Peptide CDMO Services Business (2018-2023)
10.10.5 Merck Recent Development
10.11 Asymchem
10.11.1 Asymchem Company Details
10.11.2 Asymchem Business Overview
10.11.3 Asymchem Peptide CDMO Services Introduction
10.11.4 Asymchem Revenue in Peptide CDMO Services Business (2018-2023)
10.11.5 Asymchem Recent Development
10.12 Zhejiang Jiuzhou Pharmaceutical
10.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
10.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
10.12.3 Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Introduction
10.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Peptide CDMO Services Business (2018-2023)
10.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
10.13 Sinopep
10.13.1 Sinopep Company Details
10.13.2 Sinopep Business Overview
10.13.3 Sinopep Peptide CDMO Services Introduction
10.13.4 Sinopep Revenue in Peptide CDMO Services Business (2018-2023)
10.13.5 Sinopep Recent Development
10.14 Frontier Biotechnologies
10.14.1 Frontier Biotechnologies Company Details
10.14.2 Frontier Biotechnologies Business Overview
10.14.3 Frontier Biotechnologies Peptide CDMO Services Introduction
10.14.4 Frontier Biotechnologies Revenue in Peptide CDMO Services Business (2018-2023)
10.14.5 Frontier Biotechnologies Recent Development
10.15 JYMed
10.15.1 JYMed Company Details
10.15.2 JYMed Business Overview
10.15.3 JYMed Peptide CDMO Services Introduction
10.15.4 JYMed Revenue in Peptide CDMO Services Business (2018-2023)
10.15.5 JYMed Recent Development
10.16 Chengdu Shengnuo Biotechnology
10.16.1 Chengdu Shengnuo Biotechnology Company Details
10.16.2 Chengdu Shengnuo Biotechnology Business Overview
10.16.3 Chengdu Shengnuo Biotechnology Peptide CDMO Services Introduction
10.16.4 Chengdu Shengnuo Biotechnology Revenue in Peptide CDMO Services Business (2018-2023)
10.16.5 Chengdu Shengnuo Biotechnology Recent Development
10.17 Shanghai Soho-Yiming Pharmaceuticals
10.17.1 Shanghai Soho-Yiming Pharmaceuticals Company Details
10.17.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
10.17.3 Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Introduction
10.17.4 Shanghai Soho-Yiming Pharmaceuticals Revenue in Peptide CDMO Services Business (2018-2023)
10.17.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development
10.18 Chinese Peptide Company
10.18.1 Chinese Peptide Company Company Details
10.18.2 Chinese Peptide Company Business Overview
10.18.3 Chinese Peptide Company Peptide CDMO Services Introduction
10.18.4 Chinese Peptide Company Revenue in Peptide CDMO Services Business (2018-2023)
10.18.5 Chinese Peptide Company Recent Development
10.19 Ambio Pharmaceuticals
10.19.1 Ambio Pharmaceuticals Company Details
10.19.2 Ambio Pharmaceuticals Business Overview
10.19.3 Ambio Pharmaceuticals Peptide CDMO Services Introduction
10.19.4 Ambio Pharmaceuticals Revenue in Peptide CDMO Services Business (2018-2023)
10.19.5 Ambio Pharmaceuticals Recent Development
10.20 Zhejiang Peptites Biotech
10.20.1 Zhejiang Peptites Biotech Company Details
10.20.2 Zhejiang Peptites Biotech Business Overview
10.20.3 Zhejiang Peptites Biotech Peptide CDMO Services Introduction
10.20.4 Zhejiang Peptites Biotech Revenue in Peptide CDMO Services Business (2018-2023)
10.20.5 Zhejiang Peptites Biotech Recent Development
10.21 STA Pharmaceutical
10.21.1 STA Pharmaceutical Company Details
10.21.2 STA Pharmaceutical Business Overview
10.21.3 STA Pharmaceutical Peptide CDMO Services Introduction
10.21.4 STA Pharmaceutical Revenue in Peptide CDMO Services Business (2018-2023)
10.21.5 STA Pharmaceutical Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Peptide CDMO Services Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Peptide CDMO Services Market Trends
Table 3. Peptide CDMO Services Market Drivers
Table 4. Peptide CDMO Services Market Challenges
Table 5. Peptide CDMO Services Market Restraints
Table 6. Global Peptide CDMO Services Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Peptide CDMO Services Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Peptide CDMO Services Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Peptide CDMO Services Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Peptide CDMO Services, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Peptide CDMO Services Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Peptide CDMO Services Revenue Share by Player, 2018-2023
Table 13. Global Peptide CDMO Services Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peptide CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CDMO Services as of 2022)
Table 15. Global Key Players of Peptide CDMO Services, Headquarters and Area Served
Table 16. Global Key Players of Peptide CDMO Services, Product and Application
Table 17. Global Key Players of Peptide CDMO Services, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Peptide CDMO Services in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Peptide CDMO Services Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Peptide CDMO Services Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Peptide CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Peptide CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Peptide CDMO Services Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Peptide CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Peptide CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Peptide CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Peptide CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Peptide CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Peptide CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Peptide CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Peptide CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Peptide CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Peptide CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Peptide CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Peptide CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Peptide CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Peptide CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Peptide CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Peptide CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Peptide CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Peptide CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Peptide CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Peptide CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Peptide CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Peptide CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Peptide CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Peptide CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Peptide CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Peptide CDMO Services Market Size by Region (2024-2033) & (US$ Million)
Table 51. Incyte Company Details
Table 52. Incyte Business Overview
Table 53. Incyte Peptide CDMO Services Product
Table 54. Incyte Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 55. Incyte Recent Development
Table 56. Gliead Company Details
Table 57. Gliead Business Overview
Table 58. Gliead Peptide CDMO Services Product
Table 59. Gliead Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 60. Gliead Recent Development
Table 61. Boehringer Ingelheim Company Details
Table 62. Boehringer Ingelheim Business Overview
Table 63. Boehringer Ingelheim Peptide CDMO Services Product
Table 64. Boehringer Ingelheim Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 65. Boehringer Ingelheim Recent Development
Table 66. Vertex Company Details
Table 67. Vertex Business Overview
Table 68. Vertex Peptide CDMO Services Product
Table 69. Vertex Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 70. Vertex Recent Development
Table 71. Mirati Therapeutics Company Details
Table 72. Mirati Therapeutics Business Overview
Table 73. Mirati Therapeutics Peptide CDMO Services Product
Table 74. Mirati Therapeutics Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 75. Mirati Therapeutics Recent Development
Table 76. AMPAC Company Details
Table 77. AMPAC Business Overview
Table 78. AMPAC Peptide CDMO Services Product
Table 79. AMPAC Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 80. AMPAC Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Peptide CDMO Services Product
Table 84. Pfizer Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Polypeptide Company Details
Table 87. Polypeptide Business Overview
Table 88. Polypeptide Peptide CDMO Services Product
Table 89. Polypeptide Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 90. Polypeptide Recent Development
Table 91. Bachem Company Details
Table 92. Bachem Business Overview
Table 93. Bachem Peptide CDMO Services Product
Table 94. Bachem Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 95. Bachem Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Peptide CDMO Services Product
Table 99. Merck Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 100. Merck Recent Development
Table 101. Asymchem Company Details
Table 102. Asymchem Business Overview
Table 103. Asymchem Peptide CDMO Services Product
Table 104. Asymchem Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 105. Asymchem Recent Development
Table 106. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 107. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 108. Zhejiang Jiuzhou Pharmaceutical Peptide CDMO Services Product
Table 109. Zhejiang Jiuzhou Pharmaceutical Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 110. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 111. Sinopep Company Details
Table 112. Sinopep Business Overview
Table 113. Sinopep Peptide CDMO Services Product
Table 114. Sinopep Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 115. Sinopep Recent Development
Table 116. Frontier Biotechnologies Company Details
Table 117. Frontier Biotechnologies Business Overview
Table 118. Frontier Biotechnologies Peptide CDMO Services Product
Table 119. Frontier Biotechnologies Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 120. Frontier Biotechnologies Recent Development
Table 121. JYMed Company Details
Table 122. JYMed Business Overview
Table 123. JYMed Peptide CDMO Services Product
Table 124. JYMed Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 125. JYMed Recent Development
Table 126. Chengdu Shengnuo Biotechnology Company Details
Table 127. Chengdu Shengnuo Biotechnology Business Overview
Table 128. Chengdu Shengnuo Biotechnology Peptide CDMO Services Product
Table 129. Chengdu Shengnuo Biotechnology Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 130. Chengdu Shengnuo Biotechnology Recent Development
Table 131. Shanghai Soho-Yiming Pharmaceuticals Company Details
Table 132. Shanghai Soho-Yiming Pharmaceuticals Business Overview
Table 133. Shanghai Soho-Yiming Pharmaceuticals Peptide CDMO Services Product
Table 134. Shanghai Soho-Yiming Pharmaceuticals Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 135. Shanghai Soho-Yiming Pharmaceuticals Recent Development
Table 136. Chinese Peptide Company Company Details
Table 137. Chinese Peptide Company Business Overview
Table 138. Chinese Peptide Company Peptide CDMO Services Product
Table 139. Chinese Peptide Company Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 140. Chinese Peptide Company Recent Development
Table 141. Ambio Pharmaceuticals Company Details
Table 142. Ambio Pharmaceuticals Business Overview
Table 143. Ambio Pharmaceuticals Peptide CDMO Services Product
Table 144. Ambio Pharmaceuticals Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 145. Ambio Pharmaceuticals Recent Development
Table 146. Zhejiang Peptites Biotech Company Details
Table 147. Zhejiang Peptites Biotech Business Overview
Table 148. Zhejiang Peptites Biotech Peptide CDMO Services Product
Table 149. Zhejiang Peptites Biotech Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 150. Zhejiang Peptites Biotech Recent Development
Table 151. STA Pharmaceutical Company Details
Table 152. STA Pharmaceutical Business Overview
Table 153. STA Pharmaceutical Peptide CDMO Services Product
Table 154. STA Pharmaceutical Revenue in Peptide CDMO Services Business (2018-2023) & (US$ Million)
Table 155. STA Pharmaceutical Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide CDMO Services Product Picture
Figure 2. Global Peptide CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Peptide CDMO Services Market Size 2018-2033 (US$ Million)
Figure 4. United States Peptide CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Peptide CDMO Services Market Size 2018-2033 (US$ Million)
Figure 6. United States Peptide CDMO Services Market Share in Global 2018-2033
Figure 7. Peptide CDMO Services Report Years Considered
Figure 8. Product Picture of Small Molecule CDMO
Figure 9. Product Picture of Macro-molecular CDMO
Figure 10. Global Peptide CDMO Services Market Share by Type in 2022 & 2033
Figure 11. Global Peptide CDMO Services Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Peptide CDMO Services Market Share by Type (2018-2033)
Figure 13. United States Peptide CDMO Services Market Share by Type in 2022 & 2033
Figure 14. United States Peptide CDMO Services Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States Peptide CDMO Services Market Share by Type (2018-2033)
Figure 16. Product Picture of Clinical Treatment
Figure 17. Product Picture of Medical Research
Figure 18. Product Picture of Commercial Production
Figure 19. Global Peptide CDMO Services Market Share by Application in 2022 & 2033
Figure 20. Global Peptide CDMO Services Market Size by Application (2018-2033) & (US$ Million)
Figure 21. Global Peptide CDMO Services Market Share by Application (2018-2033)
Figure 22. United States Peptide CDMO Services Market Share by Application in 2022 & 2033
Figure 23. United States Peptide CDMO Services Market Size by Application (2018-2033) & (US$ Million)
Figure 24. United States Peptide CDMO Services Market Share by Application (2018-2033)
Figure 25. The Top 5 and 10 Largest Companies of Peptide CDMO Services in the World: Market Share by Peptide CDMO Services Revenue in 2022
Figure 26. Global Peptide CDMO Services Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 27. Global Peptide CDMO Services Market Share by Region (2018-2033)
Figure 28. Americas Peptide CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 29. Americas Peptide CDMO Services Market Share by Type (2018-2033)
Figure 30. Americas Peptide CDMO Services Market Share by Application (2018-2033)
Figure 31. United States Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 32. Canada Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Mexico Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Brazil Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. EMEA Peptide CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 36. EMEA Peptide CDMO Services Market Share by Type (2018-2033)
Figure 37. EMEA Peptide CDMO Services Market Share by Application (2018-2033)
Figure 38. Europe Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Middle East Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Africa Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. China Peptide CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 42. China Peptide CDMO Services Market Share by Type (2018-2033)
Figure 43. China Peptide CDMO Services Market Share by Application (2018-2033)
Figure 44. APAC Peptide CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. APAC Peptide CDMO Services Market Share by Type (2018-2033)
Figure 46. APAC Peptide CDMO Services Market Share by Application (2018-2033)
Figure 47. Japan Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 48. South Korea Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. China Taiwan Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. India Peptide CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. Incyte Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 53. Gliead Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 55. Vertex Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 56. Mirati Therapeutics Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 57. AMPAC Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 59. Polypeptide Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 60. Bachem Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 61. Merck Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 62. Asymchem Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 63. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 64. Sinopep Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 65. Frontier Biotechnologies Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 66. JYMed Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 67. Chengdu Shengnuo Biotechnology Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 68. Shanghai Soho-Yiming Pharmaceuticals Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 69. Chinese Peptide Company Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 70. Ambio Pharmaceuticals Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 71. Zhejiang Peptites Biotech Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 72. STA Pharmaceutical Revenue Growth Rate in Peptide CDMO Services Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries